Although Ouchi et al [13] showed that increased non-canonical Wnt5a/JNK1 pathway expression in adipose tissue led to enhanced insulin resistance and fatty liver, the influence of hepatic Wnt5a signaling pathway on NASH is still not researched and remains unknown at present. Here, WNT5A is linked to metabolic dysfunction-associated steatohepatitis.